Viewing Study NCT01290393


Ignite Creation Date: 2025-12-25 @ 1:17 AM
Ignite Modification Date: 2026-01-24 @ 3:00 PM
Study NCT ID: NCT01290393
Status: TERMINATED
Last Update Posted: 2018-07-26
First Post: 2011-02-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Infections, Papillomavirus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None vaccine View
None Spontaneous abortions View
None Human papillomavirus View
None HPV View
None Cervarix View
None pregnancy View